Current approach to the treatment of polymyositis and dermatomyositis

Current Opinion in Rheumatology

Volumn 12, Issue 6, 2000, Pages 492-497

  Oddis, Chester V ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS;

CALCINOSIS; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DERMATOMYOSITIS; DOSE RESPONSE; DRUG EFFICACY; ESOPHAGUS DISEASE; GROWTH RETARDATION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLITIS; MYOCARDITIS; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SKIN DISEASE;

ADRENAL CORTEX HORMONES; CYCLOSPORINE; DERMATOMYOSITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES; POLYMYOSITIS;

EID: 0033745190     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200011000-00003     Document Type: Review

References (28)

1. Idiopathic inflammatory diseases
2. Prednisone and azathioprine for polymyositis
3. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis
4. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis
5. Treatment of refractory myositis
6. Functional outcome of myositis patients: Can a low-dose glucocorticoid regimen achieve good functional results?
7. Juvenile dermatomyositis (JDMS): Decreased calcinosis (Ca++) with intermittent high-dose intravenous methylprednisolone (IV pulse) therapy
8. Long-term prognosis of patients with juvenile dermatomyositis initially treated with intravenous methylprednisolone pulse therapy
9. Course of treated juvenile dermatomyositis
10. The effect of methylprednisolone pulse therapy in polymyositis/dermatomyositis
11. A pilot study: Use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures
12. Polyarticular disability: A functional assessment
13. Tacrolimus in refractory polymyositis with interstitial lung disease
14. Cyclosporine A therapy in refractory juvenile dermatomyositis: Experience and long-term follow-up of 6 cases
15. Preliminary evidence of cyclosporine A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis
16. Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis
17. Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases
18. Pulse intravenous cyclophosphamide treatment for steroid·resistant interstitial pneumonitis associated with polymyositis
19. Cyclosporine treatment for polymyositis/dermatomyositis: Is it possible to rescue the deteriorating cases with interstitial pneumonitis?
20. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: Prediction and treatment with cyclosporine
21. Interstitial lung disease in dermatomyositis: Clinicopathological study
22. Dermatomyositis without creatine kinase elevation. A poor prognostic sign
23. Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO- and CD45RO+ subsets
24. Low-dose intravenous immunoglobulin therapy for intractable dermatomyositis skin lesions
25. Cutaneous ulcers of refractory adult dermatomyositis responsive to intravenous immunoglobulin
26. A therapeutic update on dermatomyositis/polymyositis
27. High-dose intravenous immunoglobulin (IVIG) in dermatomyositis: Clinical responses and effect on sIL-2R levels
28. Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis